RDNTRadNet, Inc.

$72.00

Price

$72.00+8.6%1Y
1M+5.6%1Y+8.6%

Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.

Smart Score

Above average
7/10
Value63
Quality52
Momentum42
Growth66
Strongest Growth, weakest Momentum · ranked vs Healthcare peers. The five questions below judge the company on its own terms.
What they do

We are a leading national provider of diagnostic imaging services in the United States based on number of locations and annual imaging revenue. We have been in business since 1985. Our principal business segment is the provision of diagnostic imaging services. As of December 31, 2025, we operated, directly or indirectly through hospital and health system joint ventures, 418 imaging centers located in Arizona, California, Delaware, Florida, Maryland, Virginia, New Jersey, Texas and New York.

In the company’s own words · 10-K filed Mar 2, 2026 · SEC EDGAR

P/E (TTM)-
Market Cap$4.72B
1Y Return+8.6%
5Y Return+116%

Business segments

Q2 2026 · $593.0M

The company’s own SEC segment disclosure.

  • Commercial Insurance1$339.4M57%
  • Medicare1$150.8M25%
  • Other Payors$36.8M6%
  • Capitation Arrangements$30.1M5%
  • Medicaid1$14.5M2%
  • Workers Compensation Personal Injury1$13.5M2%
  • Other (1)$7.9M1%

RadNet, Inc. (RDNT) reported revenue of $623M in Q2 2026 (quarter ended Jun 30, 2026), up 25% from the same quarter a year earlier. That came with net income of $7.5M (1.2% of revenue). For the full year FY2025, revenue was $2.04B (+12% year on year) and net income −$19M. Its largest product in Q2 2026 was Commercial Insurance1 at $339M, 57% of the disclosed total, well ahead of Medicare1 at 25%.

Raw charts

11 series · TTM

As reported to the SEC, without any scoring.